Penn Medicine Penn Neuromuscular Symposium

Overview

The Penn Neuromuscular Symposium is an annual educational program designed to deliver a comprehensive and practical update on the diagnosis and management of neuromuscular disorders. This course combines expert-led presentations with case-based discussions to equip clinicians with the knowledge and tools needed to manage a broad range of neuromuscular conditions effectively.

Participants will gain insights into interpreting diagnostic studies, applying evidence-based treatment strategies, and integrating recent advances into clinical practice. The program also highlights newly approved therapies and emerging innovations that are shaping the future of neuromuscular medicine.

Location: Smilow Center, Rubenstein Auditorium, Philadelphia, PA
Course Date: Saturday, March 21, 2026

---

Learning Objectives

Upon completion of this activity, participants will be able to:

• Describe novel and emerging therapies for myasthenia gravis, including their mechanisms of action.
• Discuss new diagnostic approaches and treatment strategies for amyloidosis-related neuropathy.
• Differentiate types of demyelinating neuropathies and apply current diagnostic and management approaches.
• Review recent advances in the treatment of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), including approved therapies and ongoing clinical trials.
• Identify and manage pulmonary complications associated with neuromuscular diseases.
• Utilize antibody testing in diagnosing inflammatory myopathies and evaluate emerging therapeutic options.
• Examine the role of gene therapy in hereditary myopathies and its clinical applications.
• Apply clinical reasoning through complex case discussions to improve diagnostic and management skills.
• Discuss advancements in the diagnosis and treatment of hereditary neuropathies.

---

Target Audience

This program is designed for neurologists and neuromuscular specialists seeking up-to-date knowledge on gene therapies, myasthenia gravis treatments, and neuropathies.

---

Program Topics

• Advances in Gene- and RNA-Targeted Therapies for SMA and ALS
• Antibody Testing and Novel Therapies in Inflammatory Myopathies
• Diagnosing and Managing Demyelinating Neuropathies
• Hereditary Neuropathies, Including hATTR: New Insights and Treatments
• Integrating Novel Treatments in Myasthenia Gravis
• Neuromuscular Case Presentations

---

This symposium offers a focused and clinically relevant learning experience for healthcare professionals committed to advancing patient care in neuromuscular medicine.